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INTRODUCTION
In recent years, changes in the endothelial function,
particularly, changes in the L-arginine–NO pathway,
ensuring optimum NO generation, have been consid-
ered to be of great importance in the pathogenesis of
coronary heart disease (CHD), arterial hypertension,
and other diseases. Disorders of the oxygen transport
function of the blood (OTFB) are also of great impor-
tance in the development of these pathologies [1]. The
problem of investigation of the physiological effects of
NO acquired a new aspect, namely, the interaction of
NO with different blood components, including hemo-
globin. There are three main NO-containing hemoglo-
bin derivatives: nitrosylhemoglobin, nitrosohemoglo-
bin, and methemoglobin. These compounds differently
influence the oxygen affinity of hemoglobin (OAH),
which is of great importance for gas exchange pro-
cesses [2]. However, the state of the OTFB, especially,
in dependence on the severity of CHD, remains largely
unknown, and the results of several relevant studies are
contradictory [3]. Nitric drugs used in cardiology act
not only through NO-dependent mechanisms and the
regulation of the vascular tone and blood flow volume,
but also through interaction with hemoglobin [2].
The objective of this work was to study the state of
the OTFB in patients with stable exertional angina
(SEA) whose L-arginine–NO pathway, in the given
case, was corrected by nitrosorbide therapy.
MATERIALS AND METHODS
We studied 45 SEA inpatients (functional classes
(FCs) I–III). The mean age of the patients was 
 
52.9 
 
±
 
1.13
 
 years. To ensure group uniformity, we examined
only male patients. Patients with any associated pathol-
ogy directly influencing the OTFB were excluded from
the analysis. The effect of two-week nitrosorbide ther-
apy (40 mg per day) was assessed for 15 SEA patients
(FC II). The control group comprised 28 male donors
aged from 35 to 55 years.
Upon the admission to the hospital and at the end of
the treatment, we took blood from the ulnar vein of the
patients immediately after the recovery of the outflow.
For each blood sample, we determined oxygen tension
(
 
p
 
O
 
2
 
), CO
 
2
 
 tension (
 
p
 
ë
 
O
 
2
 
), and pH using an ABL-330
gas analyzer (Radiometer). The buffer base excess (BE)
and standard bicarbonate (SBC) were calculated using
Siggaard-Andersen charts. Using a polarimeter, we also
estimated the O
 
2
 
 content in the blood (C
 
v
 
O
 
2
 
) and oxy-
gen capacity (OC); the values obtained were used to
estimate the blood oxygenation level (
 
S
 
O
 
2
 
). The OAH
was estimated by the 
 

 
50
 
 parameter (
 

 
é
 
2
 
 value at a
blood oxygenation of 50%) determined using the
method of mixing [4] at 
 
37°ë, 
 
p
 
ç
 
 7.4
 
, and a 
 
p
 
ëé
 
 of
40 mm Hg (
 
p
 
50
 
stand
 
). The 
 

 
50
 
value for the actual 
 
p
 
ç
 
,
 
p
 
ëé
 
2
 
, and temperature (
 

 
50
 
real
 
) was calculated on the
basis of the 
 

 
50
 
stand
 
 value according to [4] at a temper-
ature coefficient of 0.24. The methemoglobin content
(MetHb) was determined spectrophotometrically;
2,3-diphosphoglycerate (2,3-DPG) was investigated
using nonenzymatic tehcniques.
The parameters of central hemodynamics were
determined by the tetrapolar rheography method and
were used to calculate the stroke index (SI) and stroke
volume index (SVI). The system oxygen capacity
(SOC) was calculated using the following formula:
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Abstract
 
—The oxygen transport function of the blood was studied in angina pectoris patients treated with
nitrosorbide to correct the L-arginine–NO pathway. A series of parameters (the O
 
2
 
 content of venous blood,
blood oxygen capacity, blood oxygenation level, methemoglobin content, oxygen affinity of methemoglobin,
and central hemodynamic parameters) were determined. The oxygen affinity of hemoglobin in patients with
functional class I and II stable exertional angina decreased according to the severity of the disease and, there-
fore, can be considered a criterion of an unfavorable course of the disease. Nitrosorbide therapy resulted in an
increase in the oxygen affinity of hemoglobin.
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SOC = , where CO is the cardiac output
(ml) and 
 
ë
 
‡
 
O
 
2
 
 is the O
 
2
 
 content in 100 ml of arterial
blood. To estimate the efficiency and functioning of the
OAH, the oxygen utilization coefficient (OUC) and the
volume of venous oxygen return (VOR) were deter-
mined: OUC = , VOR = 
 
S
 
v
 
O
 
2 
 
× 
 
 [5].
The statistical treatment of the data obtained was
carried out using a PC and the StatGraphics statistical
software.
RESULTS AND DISCUSSION
The table shows that, compared to healthy subjects,
patients with FC I SEA exhibited a decrease in 
 
S
 
v
 
O
 
2
 
 and
 
p
 
CO
 
2
 
 and an increase in the pH of the blood and 
 
p
 
50
 
value (by 27.6%). Probably, this is a typical tissue reac-
tion to hypoxia caused by coronary circulatory insuffi-
ciency. This is confirmed by an increase in the 2,3-DPG
content in red cells (
 
p
 
 < 0.01), which, in most cases (11
patients), was correlated with the 
 
p
 
50
 
 value. The values
of other parameters did not differ from those of healthy
subjects.
In the case of patients with FC II SEA, the OAH
value was also decreased (
 
p
 
50
 
stand
 
 increased by 9.7%
compared to the control group), but was lower by
14.1% (
 
p
 
 < 0.001) than that of the previous group.
CO
100--------CaO2,
SOC – VOR
SOC------------------------------
CO
100--------.
 
Probably, this was caused by a certain “exhaustion” of
the compensatory reaction of the body, which is con-
firmed by both a smaller (in comparison with the previ-
ous group) increase in the 2,3-DPG content in red cells
(
 
p
 
 < 0.05) and a decrease in the 
 
p
 
O
 
2
 
, 
 
C
 
v
 
O
 
2
 
, and 
 
S
 
v
 
O
 
2
 
values. The above-mentioned OTFB indices did not
depend significantly on the state of central hemody-
namics since these indices were the same in both
groups of SEA patients (FCs I and II). At the same time,
the MetHb content in both groups of SEA patients also
did not differ significantly from that of the control
group.
As the severity of the disease increased (FC III), the
 
p
 
5
 
 value did not differ from that of healthy subjects.
Probably, this fact can be considered a criterion of an
unfavorable course of the disease because conditions
for worsening of oxygenation are formed. At the same
time, the 
 
p
 
O
 
2
 
, 
 
C
 
v
 
O
 
2
 
,
 
 and 
 
S
 
v
 
O
 
2
 
 values were lower than in
the control group.
A decrease in OAH in patients with FC II SEA
should be considered as a compensatory reaction of tis-
sues to hypoxia caused by coronary circulatory insuffi-
ciency. The rightward shift of the oxyhemoglobin dis-
sociation curve (OAH decrease) provided better blood
deoxygenation and, obviously, optimized the tissue
oxygen consumption rate [10]. On the contrary, during
severe hypoxia (FC III), this curve shifted leftwards,
ensuring, to some degree, the maintenance of prooxi-
 
Indices of the oxygen transport function of the blood and the oxygen transport system in patients with SEA of FCs I–III (
 
M
 
 
 
±
 
 
 
m
 
)
 Indices Control group FC I SEA FC II SEA FC III SEA
 
n
 
28 13 15 17
 
MetHb
 
, % 0.593 
 
± 
 
0.069 0.42 
 
± 
 
0.039 0.67 
 
± 
 
0.075 0.61 
 
± 
 
0.079
 
p
 
O
 
2
 
, mm Hg 36.01 
 
± 
 
1.39 35.9 
 
± 
 
1.49 28.8 
 
± 
 
1,24
 
Ψ
 
,* 27.5 
 
± 
 
1,11
 
Ψ
 
,*
C
 
v
 
O
 
2
 
, vol % 12.30 
 
± 
 
0.54 12.47 
 
± 
 
1.80 9.35 
 
± 
 
0,74
 
Ψ
 
,* 9.86 
 
± 
 
0,76
 
Ψ
 
,*
OC, vol % 20.59 
 
± 
 
0.34 20.60 
 
± 
 
0.80 22.35 
 
± 
 
0.68 20.99 
 
± 
 
0.75
 
S
 
O
 
2
 
, % 62.39 
 
± 
 
2.45 53.04 
 
± 
 
3,61
 
Ψ
 
45.46 
 
± 
 
2,76
 
Ψ
 
46.79 
 
± 
 
2,86
 
Ψ
 
p
 
50
 
real
 
, mm Hg 28.42 ± 0.31 34.9 ± 109Ψ 31.2 ± 0,90Ψ,* 28.2 ± 0.71*,#
p50stand, mm Hg 26.64 ± 0.32 34.0 ± 0,97Ψ 29.2 ± 0,67Ψ,* 26.9 ± 0.85*, #
2,3-DPG, µM/ml 4.19 ± 0.096 6.80 ± 0,403Ψ 5.76 ± 0,508Ψ 4.54 ± 0.34*
pCO2, mm Hg 47.46 ± 1.05 40.2 ± 1,96Ψ 45.03 ± 1.82 47.4 ± 1.92
pH 7.326 ± 0.005 7.372 ± 0,011Ψ 7.354 ± 0.015 7.357 ± 0.012
SBC, mM 41.23 ± 1.12 46.66 ± 1.31 48.40 ± 1.09 48.55 ± 0.63
BE, mM 0.92 ± 0.12 1.35 ± 0.38 0.33 ± 0.92 0.52 ± 0.69
SI, mm/m2 37.12 ± 2.80 36.21 ± 3.30 34.26 ± 2.0 28.38 ± 2.39
SVI, l/(min m2) 2.89 ± 0.17 2.51 ± 0.10 2.15 ± 0.10 1.91 ± 0.15*
VO2, cm3/min 352.4 ± 29.88 354.5 ± 72.60 373.4 ± 33.16 399.2 ± 31.12
OUC, ml/min 0.403 ± 0.0312 0.468 ± 0.0362 0.544 ± 0.0367 0.531 ± 0.0280
SOC, ml/min 875.1 ± 51.14 719.2 ± 92.21 732.8 ± 62.14 748.3 ± 39.81
VOR, ml/min 522.7 ± 34.20 364.3 ± 29.94 35.91 ± 48.30 349.1 ± 27.0
Note: For abbreviations, see the text; Ψ, in comparison with the control value; *, in comparison with FC I SEA; #, in comparison with FC
II SEA.
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dant–antioxidant equilibrium and, possibly, exerting a
marked antioxidant effect in the case of significant dis-
orders in oxygen utilization in tissues.
After nitrosorbide therapy, we observed a decrease
in the 50stand value with a corresponding leftward shift
of the oxyhemoglobin dissociation curve. At the same
time, we recorded a reduction of pO2 and pH; pCO2 and
MetHb content values increased from 0.67 ± 0.075 to
1.182 ± 0.186%, p < 0.01 (figure). This nitrosorbide
influence on the OAH was especially pronounced in
patients with a high pretreatment p50real value (31.2 ±
0.9 mm Hg or more). This blood parameter changed
simultaneously with a decrease in the 2,3-DPG concen-
tration. It is known that nitrosorbide is an endogenous
source of NO, and its generation plays an important
role in vascular tone regulation and blood flow increase.
Probably, this is why nitrosorbide therapy optimizes the
OTFB state. In the case of endothelial dysfunction, it is
possible to maintain normal vascular function via NO
inhalation, which results in the formation of different
NO derivatives of hemoglobin and subsequent NO
release in different parts of the body [6]. We also con-
sider that NO can influence the oxygen-binding proper-
ties of hemoglobin not only through indirect hemody-
namic mechanisms, but also through a direct interac-
tion with hemoglobin, resulting in the formation of
different NO derivatives and, therefore, in a change in
the OAH [7]. This is confirmed by the pattern of
changes in the methemoglobin level. During the assess-
ment of the NO–hemoglobin interaction, the former is
considered to be an OAH-determining ligand. The
revealed positive effect of the therapy performed, based
on the modification of the L-arginine–NO pathway,
namely, nitrosorbide therapy, is obviously mediated by
changes in the OAH via an NO-dependent mechanism.
The influence of NO on the formation of oxygen-bind-
ing blood properties via the formation of different
NO−hemoglobin compounds, vascular tone regulation,
and the action of peroxynitrite may be very important
for maintenance of gas exchange processes and other
physiological functions.
CONCLUSIONS
According to our data, changes in the OAH in SEA
patients depend on the severity of the disease. At early
stages of the disease (FCs I and II), we observed a
decrease in this parameter. As the disease grew progres-
sively worse (FC III), we recorded more pronounced
disorders in the regulation of the oxygen-binding prop-
erties of hemoglobin.
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